1-6 of 6
Tove Flem Jacobsen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of Elacytarabine/Idarubicin As Second Course Remission-Induction in Patients with Acute Myeloid Leukemia Who Failed Cytarabine/Anthracycline

David A. Rizzieri, MD, Norbert Vey, MD, PhD, Xavier Thomas, MD, Françoise Huguet, Richard F Schlenk, MD, Jürgen Krauter, MD, Ph.D., Thomas Kindler, MD, Bjorn Gjertsen, MD, PhD, Igor W. Blau, Malin Johansen, Trygve Bergeland, Athos Gianella-Borradori, Tove Flem Jacobsen, Jianyu Rao, MD, Utz Krug
Journal: Blood
Blood (2012) 120 (21): 46.
https://doi.org/10.1182/blood.V120.21.46.46
Published: 2012
Journal Articles

Novel Population Pharmacokinetic Modeling of Arabinosyl Cytosine Triphosphate: Insights On Potential Preferential Formation of Ara-CTP Directly From Elacytarabine As Well As From Ara-C

Corinne Seng Yue, Varsha V. Gandhi, Ph.D., Susan O'Brien, M.D., Farhad Ravandi, MD, Tove Flem Jacobsen, Hubert Dirven, PhD, Steinar Hagen, PhD, Petter-Arnt Hals, PhD, Murray Ducharme, PhD
Journal: Blood
Blood (2012) 120 (21): 3547.
https://doi.org/10.1182/blood.V120.21.3547.3547
Published: 2012
Journal Articles

A Phase II Study of Elacytarabine/Idarubicin As Second Course Remission-Induction in Patients with Acute Myeloid Leukemia Who Failed Cytarabine/Anthracycline, and Evaluation of the Impact of the Nucleoside Transporter hENT1 on Response

David A. Rizzieri, MD, Norbert Vey, MD, Richard F. Schlenk, MD, Xavier Thomas, MD, PhD, Françoise Huguet, MD, Bjorn Gjertsen, MD, PhD, Jürgen Krauter, Igor Wolfgang Blau, Malin Johansen, Athos Gianelli-Borradori, Tove Flem Jacobsen, Jianyu Rao, MD, Utz Krug, MD
Journal: Blood
Blood (2011) 118 (21): 1533.
https://doi.org/10.1182/blood.V118.21.1533.1533
Published: 2011
Journal Articles

A Phase II Multicentre Study with Elacytarabine as Second Salvage Therapy in Patients with AML.

Susan O'Brien, M.D., David A. Rizzieri, MD, Norbert Vey, Farhad Ravandi, Utz O. Krug, Mikkael A. Sekeres, MD, MS, Mike Dennis, Adriano Venditti, MD, Tove Flem Jacobsen, Karin Staudacher, Bo I Nilsson, MD, PhD, Francis J. Giles, MB, MD, FRCPI, FRCPath
Journal: Blood
Blood (2009) 114 (22): 1042.
https://doi.org/10.1182/blood.V114.22.1042.1042
Published: 2009
Journal Articles

A Phase I/II Study with CP-4055 in Patients with Haematologic Malignancies.

Susan O’Brien, M.D., David A. Rizzieri, MD, Norbert Vey, MD, Hagop M Kantarjian, Tove Flem Jacobsen, Bo I Nilsson, MD, PhD, Karin Staudacher, Francis Giles, MD
Journal: Blood
Blood (2008) 112 (11): 949.
https://doi.org/10.1182/blood.V112.11.949.949
Published: 2008
Journal Articles

A Phase I Study with CP-4055 In Patients with Hematologic Malignancies.

Francis Giles, MD, Hagop M. Kantarjian, MD, Norbert Vey, MD, David Rizzieri, MD, Farhad Ravandi, MD, Thomas Prebet, MD, Tove Flem Jacobsen, Bo I. Nilsson, MDPhD, Karin Staudacher, Susan O’Brien, MD
Journal: Blood
Blood (2007) 110 (11): 901.
https://doi.org/10.1182/blood.V110.11.901.901
Published: 2007